Aurora Health Care treats a high volume of people with neurologic conditions like stroke and epilepsy. This means that our neurologists and neurosurgeons have a high level of experience. But we aspire to do more. We are ushering in a new era of care and treatment through clinical trials.
The future of neurologic care is at Aurora Neuroscience Innovation Institute. The institute brings together expertise, technology and our unwavering commitment to helping people thrive. Find out more about the Aurora Neuroscience Innovation Institute research program.
Highlights of our program include:
Clinical trials test the safety and effectiveness of new treatments. Trials include four phases (Phases I to IV) exploring answers to different questions about how a treatment may work in different groups of people.
New treatments start in the labs of medical device and drug companies. After the treatments pass initial safety tests, Aurora collaborates with the companies to perform clinical trials. In fact, Aurora offers access to early-phase (Phase II) clinical trials for head and neck cancer. Find out more about our early-phase clinical trials.
At Aurora, all people have the opportunity to be considered for a trial. Learn more: Clinical trials participant information.
Research at Aurora is advancing neurological disorder prevention and treatment.
Our research interests include: